Trial Profile
A phase II study of epothilone analog BMS-247550 [ixabepilone] in patients with metastatic gastric adenocarcinoma previously treated with a taxane
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2005
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.